RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Axim Biotechnologies Stock

Axim Biotechnologies Revenue 2024

Axim Biotechnologies Revenue

39,520 USD

Ticker

AXIM

ISIN

US05463V1008

WKN

A2DF26

In 2024, Axim Biotechnologies's sales reached 39,520 USD, a 295.2% difference from the 10,000 USD sales recorded in the previous year.

The Axim Biotechnologies Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
202339.52480,77
2022101900,00
202160316,67
2020--
2019--
201820095,00
201750380,00
201650-220,00
201550380,00
2014--
2013--
201240475,00
2011101900,00

Axim Biotechnologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Axim Biotechnologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Axim Biotechnologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Axim Biotechnologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Axim Biotechnologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Axim Biotechnologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Axim Biotechnologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Axim Biotechnologies’s growth potential.

Axim Biotechnologies Revenue, EBIT and net profit per share

DateAxim Biotechnologies RevenueAxim Biotechnologies EBITAxim Biotechnologies Net Income
202339,520 undefined-2.75 M undefined-8.06 M undefined
202210,000 undefined-4.65 M undefined-6.24 M undefined
202160,000 undefined-8.01 M undefined-16.03 M undefined
20200 undefined-4.95 M undefined-6.41 M undefined
20190 undefined-3.11 M undefined-6.45 M undefined
2018200,000 undefined-5.03 M undefined-6.75 M undefined
201750,000 undefined-3.15 M undefined-4.17 M undefined
201650,000 undefined-3.75 M undefined-7.28 M undefined
201550,000 undefined-10.05 M undefined-10.09 M undefined
20140 undefined-510,000 undefined-580,000 undefined
20130 undefined-60,000 undefined-90,000 undefined
201240,000 undefined-10,000 undefined-10,000 undefined
201110,000 undefined0 undefined0 undefined

Axim Biotechnologies stock margins

The Axim Biotechnologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Axim Biotechnologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Axim Biotechnologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Axim Biotechnologies's sales revenue. A higher gross margin percentage indicates that the Axim Biotechnologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Axim Biotechnologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Axim Biotechnologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Axim Biotechnologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Axim Biotechnologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Axim Biotechnologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Axim Biotechnologies Margin History

Axim Biotechnologies Gross marginAxim Biotechnologies Profit marginAxim Biotechnologies EBIT marginAxim Biotechnologies Profit margin
202395 %-6,960.63 %-20,393.93 %
202295 %-46,500 %-62,400 %
202195 %-13,350 %-26,716.67 %
202095 %0 %0 %
201995 %0 %0 %
201895 %-2,515 %-3,375 %
201795 %-6,300 %-8,340 %
2016-220 %-7,500 %-14,560 %
201595 %-20,100 %-20,180 %
201495 %0 %0 %
201395 %0 %0 %
201295 %-25 %-25 %
201195 %0 %0 %

Axim Biotechnologies Aktienanalyse

What does Axim Biotechnologies do?

Axim Biotechnologies Inc is an innovative biotechnology company focusing on the research, development, and marketing of pharmaceutical products, medical devices, and diagnostic tests based on cannabis. The company is headquartered in New York City and has become one of the leading companies in the industry since its founding in 2014. Axim Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Axim Biotechnologies's Sales Figures

The sales figures of Axim Biotechnologies originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Axim Biotechnologies’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Axim Biotechnologies's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Axim Biotechnologies’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Axim Biotechnologies stock

How much revenue did Axim Biotechnologies generate this year?

Axim Biotechnologies has achieved a revenue of 39,520 USD this year.

How much was the turnover of the company Axim Biotechnologies compared to the previous year?

The revenue of Axim Biotechnologies has increased by 295.2% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Axim Biotechnologies?

The revenue of Axim Biotechnologies is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Axim Biotechnologies measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Axim Biotechnologies so important for investors?

The revenue of Axim Biotechnologies is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Axim Biotechnologies pay?

Over the past 12 months, Axim Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Axim Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Axim Biotechnologies?

The current dividend yield of Axim Biotechnologies is .

When does Axim Biotechnologies pay dividends?

Axim Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Axim Biotechnologies?

Axim Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Axim Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Axim Biotechnologies located?

Axim Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Axim Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Axim Biotechnologies from 12/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/21/2024.

When did Axim Biotechnologies pay the last dividend?

The last dividend was paid out on 12/21/2024.

What was the dividend of Axim Biotechnologies in the year 2023?

In the year 2023, Axim Biotechnologies distributed 0 USD as dividends.

In which currency does Axim Biotechnologies pay out the dividend?

The dividends of Axim Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Axim Biotechnologies

Our stock analysis for Axim Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Axim Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.